#innovation policy

Are 'basic science' discoveries overvalued while applied biotech gets all the real results?

Should we fund synthetic biology startups over traditional basic research — or is that killing true discovery?

Does the "blossoming" of biotechnology startups truly democratize science, or is it just a clever way to license decades of public university research back to us at a premium?